Tungs' Taichung Metroharbour Hospital
Clinical trials sponsored by Tungs' Taichung Metroharbour Hospital, explained in plain language.
-
Gut supplement may cut toxins in dialysis patients
Disease control Recruiting nowThis study tests whether a 12-week course of a multi-species synbiotic supplement can lower harmful gut toxins and reduce inflammation in adults on hemodialysis. About 30 participants will take the supplement and have their blood and urine levels of toxins and inflammatory marker…
Phase: NA • Sponsor: Tungs' Taichung Metroharbour Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Gut health boost: new supplement trial for dialysis patients
Disease control Recruiting nowThis study is testing whether a 12-week course of a multi-species synbiotic (a mix of probiotics and prebiotics) can improve gut health and reduce harmful toxins in the blood of people on hemodialysis. The trial will enroll 30 adults who have been on dialysis for at least 3 month…
Phase: NA • Sponsor: Tungs' Taichung Metroharbour Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
AR videos may ease Post-Surgery anxiety in breast cancer patients
Symptom relief Recruiting nowThis study tests whether watching augmented reality (AR) health education videos can help reduce anxiety and depression in women after breast cancer surgery. 60 female patients will be randomly assigned to receive either standard education alone or standard education plus AR vide…
Phase: NA • Sponsor: Tungs' Taichung Metroharbour Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC